GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Retractable Technologies Inc (AMEX:RVP) » Definitions » Days Sales Outstanding

Retractable Technologies (Retractable Technologies) Days Sales Outstanding : 60.19 (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Retractable Technologies Days Sales Outstanding?

Retractable Technologies's average Accounts Receivable for the three months ended in Dec. 2023 was $9.43 Mil. Retractable Technologies's Revenue for the three months ended in Dec. 2023 was $14.29 Mil. Hence, Retractable Technologies's Days Sales Outstanding for the three months ended in Dec. 2023 was 60.19.

The historical rank and industry rank for Retractable Technologies's Days Sales Outstanding or its related term are showing as below:

RVP' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.3   Med: 54.59   Max: 76.4
Current: 62.33

During the past 13 years, Retractable Technologies's highest Days Sales Outstanding was 76.40. The lowest was 44.30. And the median was 54.59.

RVP's Days Sales Outstanding is ranked better than
51.67% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 63.94 vs RVP: 62.33

Retractable Technologies's Days Sales Outstanding declined from Dec. 2022 (81.82) to Dec. 2023 (60.19).


Retractable Technologies Days Sales Outstanding Historical Data

The historical data trend for Retractable Technologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Retractable Technologies Days Sales Outstanding Chart

Retractable Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 50.11 61.74 54.24 76.40 64.91

Retractable Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 81.82 46.24 77.48 68.00 60.19

Competitive Comparison of Retractable Technologies's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, Retractable Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Retractable Technologies's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Retractable Technologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Retractable Technologies's Days Sales Outstanding falls into.



Retractable Technologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Retractable Technologies's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (4.835 + 10.672) / 2 ) / 43.597*365
=7.7535 / 43.597*365
=64.91

Retractable Technologies's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (8.18 + 10.672) / 2 ) / 14.29*365 / 4
=9.426 / 14.29*365 / 4
=60.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Retractable Technologies  (AMEX:RVP) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Retractable Technologies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Retractable Technologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Retractable Technologies (Retractable Technologies) Business Description

Traded in Other Exchanges
N/A
Address
511 Lobo Lane, Little Elm, TX, USA, 75068-5295
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to its other products.
Executives
Thomas J Shaw director, 10 percent owner, officer: President and CEO 511 LOBO LANE, LITTLE ELM TX 75068
Braden Michael Leonard 10 percent owner 156 S. FIRST STREET, ZIONSVILLE IN 46077
Bigby Walter O Jr director 816 BENTON RD, BOSSIER CITY LA 71111
Darren E Findley director 1618 GRASSMERE RD, FRANKLIN TN 37064
Russell B Kuhlman director, officer: Vice President of Sales 511 LOBO LANE, PO BOX 9, LITTLE ELM TX 75068
Fort John W Iii director, officer: Chief Financial Officer 511 LOBO LANE, LITTLE ELM TX 75068
Amy Mack director 1701 LEGACY DRIVE SUITE 100, FRISCO TX 75034
Clarence D Zierhut director 1217 BLUEBIRD LANE, GARLAND TX 75042
Lillian E Salerno 10 percent owner 777 7TH AVENUE, UNIT 308, WASHINGTON DC 20001
Suzanne M August 10 percent owner 340 NORTH JULIA CIRCLE, ST. PETERSBURG FL 33706
Steven R Wisner director, officer: Exec. VP, Eng & Prod. 511 LOBO LANE, PO BOX 9, LITTLE ELM TX 75068
Marco Laterza director P.O. BOX 64104, EL PASO TX 79904
Jimmie Shiu director 511 LOBO LANE, P.O. BOX 9, LITTLE ELM TX 75068
Patti King director 9145 MARTIN ROAD, ROSWELL GA 30076
Michele Larios officer: Vice President/General Counsel 511 LOBO LANE, LITTLE ELM TX 75068

Retractable Technologies (Retractable Technologies) Headlines